RecruitingPhase 1 / Phase 2NCT07667400
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
Sponsor: National Cancer Institute (NCI)
Bethesda, MD
Phase 1/2 Prostate Cancer clinical trials
37 recruiting Phase 1/2 prostate cancer studies in the US. What trial phases mean
Other phases
RecruitingPhase 1 / Phase 2NCT07226986
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
Sponsor: Novartis Pharmaceuticals
Los Angeles, CA · Durham, NC · El Paso, TX · +1 more sites
RecruitingPhase 1 / Phase 2NCT07590934
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
Sponsor: AstraZeneca
Duarte, CA · Encino, CA · South Pasadena, CA · +9 more sites
RecruitingPhase 1 / Phase 2NCT07871435
GI-102 (CD80-IgG4 Fc-IL2v3) in Combination With Pasritamig in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) (JET-201)
Sponsor: GI Innovation, Inc.
New York, NY
RecruitingPhase 1 / Phase 2NCT07529717
First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer
Sponsor: AstraZeneca
Orlando, FL · East Brunswick, NJ · Hackensack, NJ · +1 more sites
RecruitingPhase 1 / Phase 2NCT05919264
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Sponsor: Parabilis Medicines, Inc.
Phoenix, AZ · Scottsdale, AZ · Tucson, AZ · +28 more sites
RecruitingPhase 1 / Phase 2NCT07189871
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Sponsor: Radiopharm Theranostics, Ltd
Dothan, AL · Grand Rapids, MI · Omaha, NE · +2 more sites
RecruitingPhase 1 / Phase 2NCT07594106
REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
Sponsor: Regeneron Pharmaceuticals
Goodyear, AZ · Duarte, CA · Tampa, FL · +3 more sites
RecruitingPhase 1 / Phase 2NCT06800313
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Sponsor: Janssen Research & Development, LLC
Colorado Springs, CO · Denver, CO · New Haven, CT · +14 more sites
RecruitingPhase 1 / Phase 2NCT07181161
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Sponsor: AstraZeneca
Fayetteville, AR · Los Angeles, CA · Towson, MD · +8 more sites
RecruitingPhase 1 / Phase 2NCT07262619
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
Sponsor: Eikon Therapeutics
Los Angeles, CA · Doral, FL · Hialeah, FL · +7 more sites
RecruitingPhase 1 / Phase 2NCT07730021
A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
Sponsor: Astellas Pharma Global Development, Inc.
Lake Success, NY · Fairfax, VA
RecruitingPhase 1 / Phase 2NCT04969315
TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma
Sponsor: Portage Biotech
Los Angeles, CA · Houston, TX
RecruitingPhase 1 / Phase 2NCT07192614
A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
Sponsor: AstraZeneca
Orlando, FL · Tampa, FL · Boston, MA · +3 more sites
RecruitingPhase 1 / Phase 2NCT04104776
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Sponsor: Novartis Pharmaceuticals
Tampa, FL · Atlanta, GA · Chicago, IL · +19 more sites
RecruitingPhase 1 / Phase 2NCT06236139
Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Fred Hutchinson Cancer Center
Seattle, WA
RecruitingPhase 1 / Phase 2NCT06751329
A Study of DM002 in Patients With Advanced Solid Tumors
Sponsor: Xadcera Biopharmaceutical (Suzhou) Co., Ltd.
San Francisco, CA · Huntersville, NC · Oklahoma City, OK · +1 more sites
RecruitingPhase 1 / Phase 2NCT05000294
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
Sponsor: University of Florida
Gainesville, FL
RecruitingPhase 1 / Phase 2NCT03972657
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
Sponsor: Regeneron Pharmaceuticals
Gilbert, AZ · Phoenix, AZ · Tucson, AZ · +21 more sites
RecruitingPhase 1 / Phase 2NCT06457919
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
New Haven, CT · Basking Ridge, NJ · Middletown, NJ · +9 more sites
RecruitingPhase 1 / Phase 2NCT07441889
HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)
Sponsor: University of Virginia
Charlottesville, VA
RecruitingPhase 1 / Phase 2NCT07258407
A Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate Cancer
Sponsor: T.O.A.D. Oncology SA
New Haven, CT
RecruitingPhase 1 / Phase 2NCT05413850
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
Sponsor: Blue Earth Therapeutics Ltd
Miami, FL · Atlanta, GA · +2 more sites
RecruitingPhase 1 / Phase 2NCT05036226
COAST Therapy in Advanced Solid Tumors and Prostate Cancer
Sponsor: Medical University of South Carolina
Charleston, SC
RecruitingPhase 1 / Phase 2NCT04946370
Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer
Sponsor: Weill Medical College of Cornell University
Boston, MA · Brooklyn, NY · New York, NY · +1 more sites
RecruitingPhase 1 / Phase 2NCT05785741
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Sponsor: DualityBio Inc.
Sacramento, CA · Santa Monica, CA · Coral Gables, FL · +12 more sites
RecruitingPhase 1 / Phase 2NCT06395519
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Sponsor: 858 Therapeutics, Inc.
Phoenix, AZ · New Haven, CT · Jacksonville, FL · +11 more sites
RecruitingPhase 1 / Phase 2NCT03424850
Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy
Sponsor: Washington University School of Medicine
St Louis, MO
RecruitingPhase 1 / Phase 2NCT06267729
Study of AZD0754 in Participants With Metastatic Prostate Cancer
Sponsor: AstraZeneca
Duarte, CA · Tampa, FL · Atlanta, GA · +10 more sites
RecruitingPhase 1 / Phase 2NCT06943521
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Sponsor: Tanabe Pharma America, Inc.
Los Angeles, CA · Grand Rapids, MI · Columbus, OH · +1 more sites
RecruitingPhase 1 / Phase 2NCT05914116
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Sponsor: DualityBio Inc.
Tucson, AZ · Los Angeles, CA · +25 more sites
RecruitingPhase 1 / Phase 2NCT04503265
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Sponsor: AtlasMedx, Incorporated
Los Angeles, CA · Baltimore, MD · Nashville, TN · +1 more sites
RecruitingPhase 1 / Phase 2NCT06782555
A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab
Sponsor: ImmunoGenesis
Houston, TX
RecruitingPhase 1 / Phase 2NCT01913106
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
Sponsor: The Methodist Hospital Research Institute
Houston, TX
Not yet recruitingPhase 1 / Phase 2NCT07668284
COQ10 and Vitamin E for Off-Target Radiation Toxicity
Sponsor: University of Nebraska
Omaha, NE
Not yet recruitingPhase 1 / Phase 2NCT07793435
A Phase 1/2 Trial of ADI-212 in mCRPC
Sponsor: Adicet Therapeutics
Redwood City, CA
Not yet recruitingPhase 1 / Phase 2NCT07796490
Neoadjuvant Intraprostatic OnabotulinumtoxinA Before Radical Prostatectomy for High-Risk Localized Prostate Cancer
Sponsor: The Methodist Hospital Research Institute
Houston, TX
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.